We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$61.5B
1-Year Est. Return
30.7%
This Fund
S&P 500
This Quarter
Est. Return
+1.21%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$61.5B
AUM Growth
+$1.63B
(+2.7%)
Cap. Flow
+$3.27B
Cap. Flow
% of AUM
5.33%
Top 10 Holdings %
Top 10 Hldgs %
15.82%
Holding
2,192
New
128
Increased
942
Reduced
851
Closed
143
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
lululemon athletica
LULU
|
+$516M |
| 2 |
American Tower
AMT
|
+$389M |
| 3 |
Paychex
PAYX
|
+$344M |
| 4 |
UnitedHealth
UNH
|
+$305M |
| 5 |
Gartner
IT
|
+$304M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$475M |
| 2 |
ExxonMobil
XOM
|
+$428M |
| 3 |
American Electric Power
AEP
|
+$289M |
| 4 |
Gilead Sciences
GILD
|
+$257M |
| 5 |
Amgen
AMGN
|
+$236M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.49% |
| 2 | Healthcare | 14.06% |
| 3 | Industrials | 11.95% |
| 4 | Financials | 11.87% |
| 5 | Consumer Discretionary | 10.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Monte Rosa Therapeutics
GLUE
$1.84B
| $26.8K | ﹤0.01% |
1,628
+305
| +23% | +$5.83K |
|
1752
Fastly Inc
FSLY
$3.21B
| $26.8K | ﹤0.01% |
921
-1,539
| -63% | -$25.3K |
|
1753
CRA International
CRAI
$1.23B
| $26.4K | ﹤0.01% |
163
-49
| -23% | -$8.84K |
|
1754
AerCap
AER
$23.9B
| $26.2K | ﹤0.01% |
+191
| New | +$27.3K |
|
1755
Diebold Nixdorf
DBD
$2.66B
| $25.2K | ﹤0.01% |
334
+223
| +201% | +$16.4K |
|
1756
Eagle Bancorp Montana
EBMT
$193M
| $25.1K | ﹤0.01% |
1,222
+62
| +5% | +$1.32K |
|
1757
Xencor
XNCR
$1.45B
| $24.8K | ﹤0.01% |
2,059
+511
| +33% | +$6.34K |
|
1758
SK Telecom
SKM
$11.5B
| $24.5K | ﹤0.01% |
+836
| New | +$23K |
|
1759
Rigel Pharmaceuticals
RIGL
$730M
| $24.4K | ﹤0.01% |
901
+381
| +73% | +$12.8K |
|
1760
Cytek Biosciences
CTKB
$560M
| $23.3K | ﹤0.01% |
5,335
+756
| +17% | +$3.57K |
|
1761
Braze
BRZE
$2.94B
| $22.9K | ﹤0.01% |
972
-22,574
| -96% | -$488K |
|
1762
BP
BP
$112B
| $22.6K | ﹤0.01% |
481
+285
| +145% | +$11.2K |
|
1763
Agilysys
AGYS
$3.19B
| $22.4K | ﹤0.01% |
315
+116
| +58% | +$10.1K |
|
1764
Champion Homes
SKY
$4.47B
| $22.2K | ﹤0.01% |
299
| – | – |
|
1765
Brown-Forman Class B
BF.B
$13.5B
| $22.1K | ﹤0.01% |
835
-40
| -5% | -$1.07K |
|
|
CBL
1766
CBL Properties
CBL
$1.84B
| $21.9K | ﹤0.01% |
571
+144
| +34% | +$5.34K |
|
1767
DaVita
DVA
$15.4B
| $21.5K | ﹤0.01% |
140
-11
| -7% | -$1.49K |
|
1768
StoneX
SNEX
$8.72B
| $21.4K | ﹤0.01% |
397
-395
| -50% | -$20K |
|
1769
Sony
SONY
$137B
| $21.3K | ﹤0.01% |
1,028
+201
| +24% | +$4.5K |
|
|
FOLD
1770
DELISTED
Amicus Therapeutics
FOLD
| $21.1K | ﹤0.01% |
1,460
+315
| +28% | +$4.51K |
|
1771
Xerox
XRX
$365M
| $21.1K | ﹤0.01% |
16,359
-92,720
| -85% | -$183K |
|
1772
KraneShares CSI China Internet ETF
KWEB
$5.51B
| $21.1K | ﹤0.01% |
741
-192
| -21% | -$6.29K |
|
|
CTLP
1773
DELISTED
Cantaloupe
CTLP
| $20.9K | ﹤0.01% |
1,936
+604
| +45% | +$6.38K |
|
1774
Orion Group Holdings
ORN
$363M
| $20.8K | ﹤0.01% |
1,911
+1,770
| +1,255% | +$21.2K |
|
|
OSG
1775
Octave Specialty Group
OSG
$259M
| $20.6K | ﹤0.01% |
4,420
| – | – |
|
Similar funds
Federated Hermes's Q1 2026 Portfolio in Review
As of Q1 2026, Federated Hermes held 2,192 positions worth $61.5B, up 2.7% from $59.9B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes deployed $3.27B of net new capital in Q1 2026, opening 128 new positions and adding to 942 existing holdings. Its largest new stake was EquipmentShare.com Inc: 1,549,176 shares worth $31.6M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $475M trimmed.
- Federated Hermes's largest Q1 2026 buy was EquipmentShare.com Inc: 1,549,176 shares worth $31.6M.
- Federated Hermes added most to lululemon athletica in Q1 2026, an estimated $516M increase.
- Federated Hermes's biggest Q1 2026 reduction was Johnson & Johnson, cutting an estimated $475M.
- Federated Hermes fully exited CyberArk in Q1 2026, selling an estimated $81.2M.
- Federated Hermes's ten largest holdings make up 16% of its $61.5B portfolio in Q1 2026.
- Federated Hermes opened 128 new positions and closed 143 in Q1 2026.
- Federated Hermes's portfolio value rose 2.7% quarter-over-quarter to $61.5B.
Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.